Accolades
Lei Li Named “Life Sciences and Healthcare Lawyer of the Year”
December 8, 2023
Lei Li has been honored as the “Life Sciences and Healthcare Lawyer of the Year” at The Legal 500 China Awards 2023. The awards recognize the “leading firms and lawyers together with the younger rising talent who are part of China’s extensive and complex legal market.”
Lei Li is the Managing Partner of Sidley’s Shanghai and Beijing offices. He advises clients on a broad range of regulatory, compliance, and government enforcement matters in China, with a particular focus on the life sciences industry and is one of the most accoladed legal practitioners in China in his areas of practice. Lei has advised multinational and local Chinese pharmaceutical and medical device companies on matters across the full spectrum of the industry and has handled some of the largest and most representative matters in the industry in China in the last decade.
Lei Li is the Managing Partner of Sidley’s Shanghai and Beijing offices. He advises clients on a broad range of regulatory, compliance, and government enforcement matters in China, with a particular focus on the life sciences industry and is one of the most accoladed legal practitioners in China in his areas of practice. Lei has advised multinational and local Chinese pharmaceutical and medical device companies on matters across the full spectrum of the industry and has handled some of the largest and most representative matters in the industry in China in the last decade.
Contacts
Offices
Capabilities
Suggested News & Insights
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026Sidley Represents Salt & Stone in Majority Stake Acquisition by AdventMarch 24, 2026#Market Access: Another Favorable Medical Products Advisory Opinion from HHS-OIG Signals New FlexibilitiesMarch 19, 2026Sidley Ranked in Chambers Europe 2026March 19, 2026Sidley Represents Crossbow Therapeutics in US$77 Million Series B FinancingMarch 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
